Aspirin use may prevent cancer
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.ONE OF the commonest cancers in Britain, which kills nearly 13,000 men and women a year, is to be tackled with one of the commonest drugs in the world - aspirin.
When American scientists set out to discover the extent that aspirin reduced deaths from heart attacks, they found that among the aspirin-takers there were fewer deaths from bowel cancer.
Newcastle University researchers are about to embark on a Europe-wide project to see if prescribing aspirin could reduce the chance of getting bowel cancer.
The pounds 300,000 survey, funded by the EC, will cover 14 countries and follow 200 people, initially until the end of 1995. Half will take aspirin and half a placebo. All will be tested once a year.
To speed the survey, researchers will concentrate on a special group suffering from a rare genetic defect which makes them susceptible to bowel cancer, a condition known as polyposis.
John Burn, Professor of Clinical Genetics, said: 'If we just used a simple cross section of the population, most would be unlikely to develop polyps, or lumps on the lining of the large intestine, which can lead to cancer.'
Most people who develop bowel cancer do so in their late fifties or sixties. People with polyposis, caused by a defective gene known as the APC gene, tend to show the first signs of disease in their teens.
Professor Burn said: 'Normal people aren't affected by the cancer until later in life because the first, non-malignant stage is so long. With the APC gene defect, people miss out on that first stage. It's as if they go straight on to stage two, where the cells start to make mistakes as they divide, which can lead to malignancy.'
This form of cancer is treatable by removing a section of the large intestine. Aspirin could, in some cases, make surgery unnecessary, or delay it for several years.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments